Abstract
Glioblastoma is an extremely aggressive type of cancer and patients with this type of tumor, even undergoing surgery, radiotherapy and chemotherapy, have an average survival of 12 to 15 months. Standard chemotherapy treatment is performed by administering temozolomide (TMZ) which is an alkylating agent that induces cell death by the formation of various DNA damage. Despite aggressive and …